These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 15018660)

  • 21. Pigs immunized with Chinese highly pathogenic PRRS virus modified live vaccine are protected from challenge with North American PRRSV strain NADC-20.
    Galliher-Beckley A; Li X; Bates JT; Madera R; Waters A; Nietfeld J; Henningson J; He D; Feng W; Chen R; Shi J
    Vaccine; 2015 Jul; 33(30):3518-25. PubMed ID: 26049004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Humoral immune responses and viral shedding following vaccination with modified live porcine reproductive and respiratory syndrome virus vaccines.
    Madapong A; Temeeyasen G; Saeng-Chuto K; Tripipat T; Navasakuljinda W; Boonsoongnern A; Tantituvanont A; Nilubol D
    Arch Virol; 2017 Jan; 162(1):139-146. PubMed ID: 27695957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant Porcine Interferon Alpha Enhances Immune Responses to Killed Porcine Reproductive and Respiratory Syndrome Virus Vaccine in Pigs.
    Yu HY; Qu MS; Zhang JL; Gan L; Zhao Y; Shan XQ; Zhou W; Xia BB; Chen J; Wang ML; Zhao J
    Viral Immunol; 2019 Nov; 32(9):383-392. PubMed ID: 31693458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune responses of pigs immunized with a recombinant porcine reproductive and respiratory syndrome virus expressing porcine GM-CSF.
    Li Z; Wang G; Wang Y; Zhang C; Huang B; Li Q; Li L; Xue B; Ding P; Cai X; Wang C; Zhou EM
    Vet Immunol Immunopathol; 2015 Nov; 168(1-2):40-8. PubMed ID: 26300317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of a killed porcine reproductive and respiratory syndrome virus (PRRSV) vaccine treatment on virus shedding in previously PRRSV infected pigs.
    Nilubol D; Platt KB; Halbur PG; Torremorell M; Harris DL
    Vet Microbiol; 2004 Aug; 102(1-2):11-8. PubMed ID: 15288922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of four commercial PRRSV MLV vaccines in herds with co-circulation of PRRSV-1 and PRRSV-2.
    Oh T; Kim H; Park KH; Jeong J; Yang S; Kang I; Chae C
    Comp Immunol Microbiol Infect Dis; 2019 Apr; 63():66-73. PubMed ID: 30961820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reproductive, productivity, and mortality outcomes in late-gestation gilts and their litters following simulation of inadvertent exposure to a modified-live vaccine strain of porcine reproductive and respiratory syndrome (PRRS) virus.
    Schelkopf A; Nerem J; Cowles B; Amodie D; Swalla R; Dee S
    Vaccine; 2014 Aug; 32(36):4639-43. PubMed ID: 24975816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A DNA-Modified Live Vaccine Prime-Boost Strategy Broadens the T-Cell Response and Enhances the Antibody Response against the Porcine Reproductive and Respiratory Syndrome Virus.
    Bernelin-Cottet C; Urien C; Stubsrud E; Jakob V; Bouguyon E; Bordet E; Barc C; Boulesteix O; Contreras V; Barnier-Quer C; Collin N; Trus I; Nauwynck H; Bertho N; Schwartz-Cornil I
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31207934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of two commercially available porcine reproductive and respiratory syndrome virus (PRRSV) modified-live virus vaccines analyzing the growth performance in 1-day-old vaccinated swine located on endemic farms co-circulating PRRSV-1 and PRRSV-2.
    Yang S; Kang I; Jeong J; Oh T; Park KH; Park SJ; Ham HJ; Jin GR; Lee BH; Chae C
    J Vet Med Sci; 2020 Feb; 82(2):224-228. PubMed ID: 31866631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A DNA Prime Immuno-Potentiates a Modified Live Vaccine against the Porcine Reproductive and Respiratory Syndrome Virus but Does Not Improve Heterologous Protection.
    Bernelin-Cottet C; Urien C; Fretaud M; Langevin C; Trus I; Jouneau L; Blanc F; Leplat JJ; Barc C; Boulesteix O; Riou M; Dysart M; Mahé S; Studsrub E; Nauwynck H; Bertho N; Bourry O; Schwartz-Cornil I
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31242645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced immune responses in pigs by DNA vaccine coexpressing GP3 and GP5 of European type porcine reproductive and respiratory syndrome virus.
    Ren J; Lu H; Wen S; Sun W; Yan F; Chen X; Jing J; Liu H; Liu C; Xue F; Xiao P; Xin S; Jin N
    J Virol Methods; 2014 Sep; 206():27-37. PubMed ID: 24882496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasmid containing CpG oligodeoxynucleotides can augment the immune responses of pigs immunized with porcine reproductive and respiratory syndrome killed virus vaccine.
    Quan Z; Qin ZG; Zhen W; Feng XZ; Hong J; Fei ZH
    Vet Immunol Immunopathol; 2010 Aug; 136(3-4):257-64. PubMed ID: 20394988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Porcine reproductive and respiratory syndrome (PRRS) virus-specific interferon-gamma(+) T-cell responses after PRRS virus infection or vaccination with an inactivated PRRS vaccine.
    Piras F; Bollard S; Laval F; Joisel F; Reynaud G; Charreyre C; Andreoni C; Juillard V
    Viral Immunol; 2005; 18(2):381-9. PubMed ID: 16035950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Commercial porcine reproductive and respiratory syndrome virus (PRRSV)-2 modified live virus vaccine against heterologous single and dual Korean PRRSV-1 and PRRSV-2 challenge.
    Jeong J; Kim S; Park C; Park KH; Kang I; Park SJ; Chae C
    Vet Rec; 2018 Apr; 182(17):485. PubMed ID: 29472439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation and characteristics of immunological adjuvant activity of purified fraction of Albizia julibrissin saponins.
    Zhu B; He T; Gao X; Shi M; Sun H
    Immunol Invest; 2019 Apr; 48(3):283-302. PubMed ID: 30325683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intranasal immunization of pigs with porcine reproductive and respiratory syndrome virus-like particles plus 2', 3'-cGAMP VacciGrade™ adjuvant exacerbates viremia after virus challenge.
    Van Noort A; Nelsen A; Pillatzki AE; Diel DG; Li F; Nelson E; Wang X
    Virol J; 2017 Apr; 14(1):76. PubMed ID: 28403874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positive immunomodulatory effects of heterologous DNA vaccine- modified live vaccine, prime-boost immunization, against the highly-pathogenic PRRSV infection.
    Sirisereewan C; Nedumpun T; Kesdangsakonwut S; Woonwong Y; Kedkovid R; Arunorat J; Thanawongnuwech R; Suradhat S
    Vet Immunol Immunopathol; 2017 Jan; 183():7-15. PubMed ID: 28063479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant danger signals increase the immune response to porcine reproductive and respiratory syndrome virus.
    Foss DL; Zilliox MJ; Meier W; Zuckermann F; Murtaugh MP
    Viral Immunol; 2002; 15(4):557-66. PubMed ID: 12513927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of different vaccination schedules for sustaining the immune response against porcine reproductive and respiratory syndrome virus.
    Díaz I; Gimeno M; Callén A; Pujols J; López S; Charreyre C; Joisel F; Mateu E
    Vet J; 2013 Aug; 197(2):438-44. PubMed ID: 23499541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of commercial genotype 1 porcine reproductive and respiratory syndrome virus (PRRSV) vaccine against field isolate of genotype 2 PRRSV.
    Ko SS; Seo SW; Sunwoo SY; Yoo SJ; Kim MH; Lyoo YS
    Vet Immunol Immunopathol; 2016 Apr; 172():43-9. PubMed ID: 27032502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.